Related Experiment Video
Updated: Mar 13, 2026
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Is Kidney Transplantation a Better State of CKD? Impact on Diagnosis and Management
Sandesh Parajuli1, Dana F Clark1, Arjang Djamali1
1Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Insights
Kidney transplantation improves kidney function but transplant recipients face higher risks of cardiovascular events, infections, and malignancies. Careful management is crucial for long-term survival in these patients.
Area of Science:
- Nephrology
- Transplantation Medicine
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) significantly increases risks for cardiovascular events, hospitalizations, and mortality.
- Kidney transplantation (KTx) is the optimal treatment for end-stage kidney disease, often improving comorbidities.
- Despite KTx benefits, recipients have elevated risks for cardiovascular mortality, infections, malignancies, fractures, and obesity.
Purpose of the Study:
- To compare the progression of CKD before and after transplantation (CKD-T).
- To highlight the unique risk factors and management needs of kidney transplant recipients.
- To emphasize strategies for improving long-term patient and allograft survival in CKD-T.
Main Methods:
- Comparative analysis of CKD progression rates (eGFR decline) in patients pre- and post-KTx.
- Review of traditional and transplant-specific risk factors in kidney transplant recipients.
- Assessment of mortality risks associated with CKD-T, including cardiovascular events, infections, and malignancies.
Main Results:
- The rate of estimated glomerular filtration rate (eGFR) decline is significantly lower in CKD-T compared to CKD.
- Despite slower eGFR decline, cardiovascular events, infections, and malignancies pose significant mortality risks.
- Kidney transplant recipients represent a unique patient group with combined traditional and transplant-related risk factors.
Conclusions:
- While KTx slows CKD progression, the increased risks of mortality from other causes necessitate specialized management.
- Effective preventive measures and tailored medical care are essential for enhancing survival rates in kidney transplant recipients.
- Addressing both CKD-T specific and general health risks is vital for optimizing outcomes in this population.
Abstract:
Patients with CKD are at increased risk for cardiovascular events, hospitalizations, and mortality. Kidney transplantation (KTx) is the preferred treatment for end-stage kidney disease. Although comorbidities including anemia and bone and mineral disease improve or are even halted after KTx, kidney transplant recipients carry higher cardiovascular mortality risk than the general population, as well as an increased risk of infections, malignancies, fractures, and obesity. When comparing CKD with CKD after transplantation (CKD-T), the rate of decline of estimated glomerular filtration rate (eGFR) is significantly lower in CKD-T. Higher rate of decline of eGFR has been associated with increased risk of mortality. However, due to the significant increased risk of mortality due to cardiovascular events, infections, and malignancies, many kidney transplant recipients may not benefit of decline in the rate of eGFR. Patients with CKD-T are a unique subset of patients with multiple traditional and transplant-specific risk factors. Proper management and appropriate preventive health measures may improve long-term patient and allograft survival in patients with CKD-T.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:28Chronic Kidney Disease III: Interprofessional Care
01:25Chronic Kidney Disease I: Introduction
01:16Kidney Transplant III: Nursing Management
01:26Kidney Transplant II: Surgical Procedure
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention